Abstract
The molecular size of type A botulinum toxin affects the response in a time-to-death assay. Definitive statements of specific activity should be based on quantal assay.
Full text
PDF![423](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c526/415916/d222ded4fa3b/iai00292-0103.png)
![424](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c526/415916/f0863cfdceae/iai00292-0104.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boroff D. A., Fleck U. Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum. J Bacteriol. 1966 Nov;92(5):1580–1581. doi: 10.1128/jb.92.5.1580-1581.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boroff D. A., Townend R., Fleck U., DasGupta B. R. Ultracentrifugal analysis of the crystalline toxin and isolated fractions of Clostridium botulinum type A. J Biol Chem. 1966 Nov 25;241(22):5165–5167. [PubMed] [Google Scholar]
- DasGupta B. R., Boroff D. A. Chromatographic isolation of hemagglutinin-free neurotoxin from crystalline toxin of Clostridium botulinum type A. Biochim Biophys Acta. 1967 Dec 12;147(3):603–605. doi: 10.1016/0005-2795(67)90024-4. [DOI] [PubMed] [Google Scholar]
- Dasgupta B. R., Boroff D. A., Rothstein E. Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A. Biochem Biophys Res Commun. 1966 Mar 22;22(6):750–756. doi: 10.1016/0006-291x(66)90212-9. [DOI] [PubMed] [Google Scholar]